Cargando…
Microbiota, co-metabolites, and network pharmacology reveal the alteration of the ginsenoside fraction on inflammatory bowel disease
BACKGROUND: Panax ginseng Meyer (P. ginseng) is a traditional natural/herbal medicine. The amelioration on inflammatory bowel disease (IBD) activity rely mainly on its main active ingredients that are referred to as ginsenosides. However, the current literature on gut microbiota, gut microbiota-host...
Autores principales: | Wang, Dandan, Guo, Mingkun, Li, Xiangyan, Zhao, Daqing, Wang, Mingxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834002/ https://www.ncbi.nlm.nih.gov/pubmed/36644384 http://dx.doi.org/10.1016/j.jgr.2022.04.001 |
Ejemplares similares
-
Pharmacological properties, molecular mechanisms and therapeutic potential of ginsenoside Rg3 as an antioxidant and anti-inflammatory agent
por: Wang, Jing, et al.
Publicado: (2022) -
Biotransformation, Pharmacokinetics, and Pharmacological Activities of Ginsenoside Rd Against Multiple Diseases
por: Li, Jing, et al.
Publicado: (2022) -
Role of intestinal microbiota and metabolites in inflammatory bowel disease
por: Dong, Li-Na, et al.
Publicado: (2019) -
Integrative network pharmacology and experimental verification to reveal the anti-inflammatory mechanism of ginsenoside Rh4
por: To, Kwang-Il, et al.
Publicado: (2022) -
Alteration of the fecal microbiota and serum metabolite profiles in dogs with idiopathic inflammatory bowel disease
por: Minamoto, Yasushi, et al.
Publicado: (2015)